Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | CASP9 |
Upstream (Parents) |
---|
(<<) ATP2B4 → CASP9 |
(<<) BCL6 → CASP9 |
(<<) CEP170 → CASP9 |
(<<) DVL1 → CASP9 |
(<<) MCL1 → CASP9 |
(<<) MSN → CASP9 |
(<<) PPIB → CASP9 |
(<<) PRPF4B → CASP9 |
(<<) PTPN11 → CASP9 |
(<<) RNASE7 → CASP9 |
(<<) SLC25A37 → CASP9 |
(<<) SPATA2L → CASP9 |
(<<) SRC → CASP9 |
(<<) STK11 → CASP9 |
(<<) TK2 → CASP9 |
(<<) YWHAE → CASP9 |
Downstream (Children) |
---|
CASP9 → CARD9 (>>) |
CASP9 → CDC42EP2 (>>) |
CASP9 → CSNK1E (>>) |
CASP9 → EIF2AK2 (>>) |
CASP9 → FZD3 (>>) |
CASP9 → GNE (>>) |
CASP9 → ILKAP (>>) |
CASP9 → MAP6D1 (>>) |
CASP9 → PITPNC1 (>>) |
CASP9 → PRKCZ (>>) |
CASP9 → RPL35A (>>) |
CASP9 → STK40 (>>) |
CASP9 → THRB (>>) |
CASP9 → TMC7 (>>) |
CASP9 → UTP18 (>>) |